logo-loader
NASDAQ:PGNX

Progenics Pharmaceuticals, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$355.05 m
Price
4.10 USD
Change
-9.39%
52 weeks high
6.35
52 weeks low
1.89

In brief

Progenics Pharmaceuticals, Inc., of Tarrytown, NY, is a biopharmaceutical company with programs in gastroenterology, oncology and virology focused on innovative therapeutics for patients with debilitating conditions and life-threatening diseases.